Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on equity (ROE) high or low?
The return on equity (ROE) of -93.77% is 55% above its 5-year average of -210.20%, near the high end of its 5-year range (-595.01%–-73.23%).
As of the fiscal period ended Tuesday, June 30, 2026. 73.37% above its 12-month average of -352.10%.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -93.77%.
RETURN ON EQUITY (ROE)
-93.77%
RETURN ON EQUITY (ROE) AVG TTM
-352.10%
RETURN ON EQUITY (ROE) AVG 3Y
-292.13%
RETURN ON EQUITY (ROE) AVG 5Y
-210.20%
RETURN ON EQUITY (ROE) AVG 10Y
-270.78%
RETURN ON EQUITY (ROE) AVG 15Y
N/A
RETURN ON EQUITY (ROE) AVG 20Y
N/A
CURRENT VS TTM AVG
+73.37%
CURRENT VS 3Y AVG
+67.90%
CURRENT VS 5Y AVG
+55.39%
CURRENT VS 10Y AVG
+65.37%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-41.15%
median of 712 covered companies
CURRENT VS SECTOR MEDIAN
-127.88%
vs the sector median at left
ENDRA Life Sciences Inc.
Market Cap
$7.81M
Return on Equity (ROE)
-93.77%
TTM Avg
-352.10%
3Y Avg
-292.13%
5Y Avg
-210.20%
Market Cap
$7.93M
Return on Equity (ROE)
N/A
TTM Avg
-642.51%
3Y Avg
-382.39%
5Y Avg
-328.67%
Market Cap
$8.01M
Return on Equity (ROE)
-91.75%
TTM Avg
-295.51%
3Y Avg
-88.38%
5Y Avg
-106.70%
Market Cap
$7.95M
Return on Equity (ROE)
-618.74%
TTM Avg
149.09%
3Y Avg
4.64%
5Y Avg
-24.92%
Market Cap
$7.59M
Return on Equity (ROE)
-85.24%
TTM Avg
23.31%
3Y Avg
-10.41%
5Y Avg
-27.01%
Market Cap
$8.13M
Return on Equity (ROE)
-31.99%
TTM Avg
-84.19%
3Y Avg
-171.49%
5Y Avg
-138.23%
Market Cap
$8.18M
Return on Equity (ROE)
N/A
TTM Avg
-2138.11%
3Y Avg
-1780.63%
5Y Avg
-1152.40%
Market Cap
$7.31M
Return on Equity (ROE)
N/A
TTM Avg
-159.14%
3Y Avg
523.81%
5Y Avg
82.41%
Market Cap
$7.31M
Return on Equity (ROE)
-1168.44%
TTM Avg
-606.51%
3Y Avg
-330.90%
5Y Avg
-270.23%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| ENDRA Life Sciences Inc. (NDRA) | $7.81M | -93.77% | -352.10% | -292.13% | -210.20% |
| Traws Pharma, Inc. (TRAW)vs › | $7.93M | N/A | -642.51% | -382.39% | -328.67% |
| CNS Pharmaceuticals, Inc. (CNSP)vs › | $8.01M | -91.75% | -295.51% | -88.38% | -106.70% |
| GT Biopharma, Inc. (GTBP)vs › | $7.95M | -618.74% | 149.09% | 4.64% | -24.92% |
| Quince Therapeutics, Inc. (QNCX)vs › | $7.59M | -85.24% | 23.31% | -10.41% | -27.01% |
| Aprea Therapeutics, Inc. (APRE)vs › | $8.13M | -31.99% | -84.19% | -171.49% | -138.23% |
| HeartSciences Inc. (HSCS)vs › | $8.18M | N/A | -2138.11% | -1780.63% | -1152.40% |
| Skye Bioscience, Inc. (SKYE)vs › | $7.31M | N/A | -159.14% | 523.81% | 82.41% |
| InMed Pharmaceuticals Inc. (INM)vs › | $7.31M | -1168.44% | -606.51% | -330.90% | -270.23% |
| Longeveron Inc. (LGVN)vs › | $7.27M | -225.67% | -236.53% | -220.64% | -186.37% |
ROE
-93.8%
ROA
-74.5%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2026-06-30 | -93.77% |
| 2026-03-31 | -408.67% |
| 2025-12-31 | -310.93% |
| 2025-06-30 | -595.01% |
| 2025-03-31 | -557.29% |
| 2024-12-31 | -449.46% |
| 2024-09-30 | -133.52% |
| 2024-06-30 | -106.35% |
| 2024-03-31 | -267.52% |
| 2023-12-31 | -177.77% |
| 2023-09-30 | -228.82% |
| 2023-06-30 | -176.46% |
| 2023-03-31 | -294.81% |
| 2022-12-31 | -182.93% |
| 2022-09-30 | -127.35% |
| 2022-06-30 | -91.58% |
| 2022-03-31 | -130.34% |
| 2021-12-31 | -104.14% |
| 2021-09-30 | -78.88% |
| 2021-06-30 | -73.23% |
| 2021-03-31 | -59.78% |
| 2020-12-31 | -163.55% |
| 2020-09-30 | -428.31% |
| 2020-03-31 | -550.35% |
| 2019-12-31 | -279.50% |
| 2019-09-30 | -774.36% |
| 2019-06-30 | -559.51% |
| 2019-03-31 | -255.66% |
| 2018-12-31 | -156.79% |
| 2018-06-30 | -405.81% |
| 2018-03-31 | -263.64% |
| 2017-12-31 | -101.92% |
| 2017-09-30 | -52.59% |
| 2017-06-30 | -49.32% |
| 2016-06-30 | -787.27% |
| 2016-03-31 | -888.44% |
| 2015-12-31 | -962.06% |
